Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL525223

CYCLOVIOLACIN O2
Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
CC[C@H](C)[C@@H]1NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)CN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc4c[nH]c5ccccc45)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N4CCC[C@H]4C(=O)N2)NC(=O)[C@H](CO)NC(=O)[C@H](CSSC[C@@H](C(=O)O)NC(=O)[C@@H]2CCCN2C(=O)[C@H]([C@@H](C)CC)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc(O)cc2)NC3=O)NC(=O)CNC1=O

Basic Information

ChEMBL ID CHEMBL525223
Name CYCLOVIOLACIN O2
Phase Preclinical
Structure Type BOTH
InChI Key LPRLNBIIZMVTNT-CGJDGIRVSA-N
8
Targets
12
Activities
1
Assay Types
0
PK Parameters
10
Publications
0
Known Names

Molecular Properties

3158.8
MW (Da)

Drug Information

Molecule Type Protein
Availability Unknown
Chirality Unknown

Flags

Natural Product First in Class Prodrug

Extended Properties

Molecular Formula C133H209N37O40S6
MW 3158.76

Activity Summary

IC50 12 meas. best 7.0

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
RPMI-8226
CHEMBL614882
IC50 7.0 6.98 100.0 2
CCRF-CEM
CHEMBL382
IC50 6.96 6.96 110.0 1
NON-PROTEIN TARGET
CHEMBL3879801
IC50 6.96 6.96 110.0 3
U-937
CHEMBL612794
IC50 6.96 6.96 110.0 1
U-937/GTB
CHEMBL612795
IC50 6.96 6.74 110.0 2
R1
CHEMBL614383
IC50 6.96 6.96 110.0 1
ACHN
CHEMBL614519
IC50 6.96 6.96 110.0 1
ADMET
CHEMBL612558
IC50 4.44 4.44 36000.0 1

Activity Data Samples

Top measurements by pChEMBL value

Target Type Rel. Value Units pChEMBL Assay PubMed
RPMI-8226 IC50 = 100.0 nM 7.0 Cytotoxicity against human RPMI8226/S cells after 72 hrs by trypan blue exclusio... 14987049
RPMI-8226 IC50 = 110.0 nM 6.96 Cytotoxicity against human RPMI8226/S cells after 72 hrs by fluorometric microcu... 20718473
NON-PROTEIN TARGET IC50 = 110.0 nM 6.96 Cytotoxicity against human 8226/DOX40 cells after 72 hrs by fluorometric microcu... 20718473
NON-PROTEIN TARGET IC50 = 110.0 nM 6.96 Cytotoxicity against human 8226/LR-5 cells after 72 hrs by fluorometric microcul... 20718473
U-937/GTB IC50 = 110.0 nM 6.96 Cytotoxicity against human U937/GTB cells after 72 hrs by fluorometric microcult... 20718473
U-937 IC50 = 110.0 nM 6.96 Cytotoxicity against human vincristine-resistant U937 cells after 72 hrs by fluo... 20718473
ACHN IC50 = 110.0 nM 6.96 Cytotoxicity against human ACHN cells after 72 hrs by fluorometric microculture ... 20718473
CCRF-CEM IC50 = 110.0 nM 6.96 Cytotoxicity against human CCRF-CEM cells after 72 hrs by fluorometric microcult... 20718473
NON-PROTEIN TARGET IC50 = 110.0 nM 6.96 Cytotoxicity against human CEM/VM1 cells after 72 hrs by fluorometric microcultu... 20718473
R1 IC50 = 110.0 nM 6.96 Cytotoxicity against mouse R1 cells after 72 hrs by fluorometric microculture cy... 20718473
U-937/GTB IC50 = 300.0 nM 6.52 Cytotoxicity against human U937/GTB cells after 72 hrs by trypan blue exclusion ... 14987049
ADMET IC50 = 36000.0 nM 4.44 Hemolytic activity in human type A RBC assessed as hemolysis after 1 hr by micro... 20718473

Literature References

PubMed DOI Target Context # Activities
20718473 10.1021/np1000413 NON-PROTEIN TARGET 3
14987049 10.1021/np030101l U-937/GTB 1
14987049 10.1021/np030101l RPMI-8226 1
20718473 10.1021/np1000413 RPMI-8226 1
20718473 10.1021/np1000413 U-937/GTB 1
20718473 10.1021/np1000413 U-937 1
20718473 10.1021/np1000413 ACHN 1
20718473 10.1021/np1000413 CCRF-CEM 1
20718473 10.1021/np1000413 R1 1
20718473 10.1021/np1000413 ADMET 1

Data from ChEMBL 36 via Core Engine